A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours: a study protocol
Crossref DOI link: https://doi.org/10.1186/1471-2407-14-983
Published Online: 2014-12-19
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nicum, Shibani
Roberts, Corran
Boyle, Lucy
Kopijasz, Sylwia
Gourley, Charlie
Hall, Marcia
Montes, Ana
Poole, Christopher
Collins, Linda
Schuh, Anna
Dutton, Susan J
License valid from 2014-12-01